Giulia Nicoletti
Overview
Explore the profile of Giulia Nicoletti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nicoletti G, Mazzetti S, Maimone G, Cignini V, Cuocolo R, Faletti R, et al.
Cancers (Basel)
. 2024 Jan;
16(1).
PMID: 38201630
In the last years, several studies demonstrated that low-aggressive (Grade Group (GG) ≤ 2) and high-aggressive (GG ≥ 3) prostate cancers (PCas) have different prognoses and mortality. Therefore, the aim...
2.
Mazzetti S, Defeudis A, Nicoletti G, Chiorino G, De Luca S, Faletti R, et al.
Eur Radiol
. 2024 Jan;
34(8):5108-5117.
PMID: 38177618
Objectives: The aims of this study are to develop and validate a clinical decision support system based on demographics, prostate-specific antigen (PSA), microRNA (miRNA), and MRI for the detection of...
3.
Nicoletti R, Nicoletti G, Giannini V, Teoh J
Prostate Cancer Prostatic Dis
. 2023 Sep;
27(1):3-4.
PMID: 37723251
No abstract available.
4.
Defeudis A, Panic J, Nicoletti G, Mazzetti S, Giannini V, Regge D
BJR Open
. 2023 Apr;
5(1):20220055.
PMID: 37035771
In recent years, researchers have explored new ways to obtain information from pathological tissues, also exploring non-invasive techniques, such as virtual biopsy (VB). VB can be defined as a test...
5.
Giannini V, Pusceddu L, Defeudis A, Nicoletti G, Cappello G, Mazzetti S, et al.
Cancers (Basel)
. 2022 Jan;
14(1).
PMID: 35008405
The purpose of this paper is to develop and validate a delta-radiomics score to predict the response of individual colorectal cancer liver metastases (lmCRC) to first-line FOLFOX chemotherapy. Three hundred...
6.
Nicoletti G, Barra D, Defeudis A, Mazzetti S, Gatti M, Faletti R, et al.
Annu Int Conf IEEE Eng Med Biol Soc
. 2021 Dec;
2021:3374-3377.
PMID: 34891963
In the last decades, MRI was proven a useful tool for the diagnosis and characterization of Prostate Cancer (PCa). In the literature, many studies focused on characterizing PCa aggressiveness, but...
7.
Barra D, Nicoletti G, Defeudis A, Mazzetti S, Panic J, Gatti M, et al.
Annu Int Conf IEEE Eng Med Biol Soc
. 2021 Dec;
2021:3370-3373.
PMID: 34891962
Automatic segmentation of the prostate on Magnetic Resonance Imaging (MRI) is one of the topics on which research has focused in recent years as it is a fundamental first step...
8.
Defeudis A, Cefaloni L, Giannetto G, Cappello G, Rizzetto F, Panic J, et al.
Annu Int Conf IEEE Eng Med Biol Soc
. 2021 Dec;
2021:3305-3308.
PMID: 34891947
Colorectal cancer (CRC) has the second-highest tumor incidence and is a leading cause of death by cancer. Nearly 20% of patients with CRC will have metastases (mts) at the time...